CD8A and neoplasm: Collectively, our in vivo and in vitro studies in the PDAC orthotopic mouse and organoid models demonstrate that PMN-MDSCs are likely to contribute to tumor growth, suppression of CD8+ T cell proliferation and effector function that may lead to disruption of the efficacy of checkpoint inhibition.